Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Q Biomed Inc. (QBIO) had Return on Tangible Equity of 41.73% for the most recently reported fiscal year, ending 2022-11-30.
| Income Statement Financials | |
$0.28M |
|
$-3.49M |
|
$0.29M |
|
$-0.01M |
|
$3.73M |
|
$-3.45M |
|
$1.39M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-2.05M |
|
$-3.45M |
|
$-2.47M |
|
44.76M |
|
44.76M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$0.07M |
|
-- |
|
$3.44M |
|
$3.52M |
|
$8.13M |
|
-- |
|
-- |
|
$8.13M |
|
$-9.70M |
|
$-4.92M |
|
$-4.62M |
|
84.33M |
|
| Cash Flow Statement Financials | |
$1.94M |
|
$-3.14M |
|
$0.91M |
|
$0.34M |
|
$0.05M |
|
$-0.29M |
|
$0.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.01 |
|
-- |
|
-- |
|
-- |
|
-0.89 |
|
-3.16% |
|
-1211.74% |
|
-1211.74% |
|
-869.70% |
|
-721.67% |
|
-1228.79% |
|
$1.94M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
-- |
|
24.65 |
|
14.81 |
|
21.15% |
|
|
Return on Tangible Equity |
41.73% |
-58.37% |
|
44.44% |
|
$-0.05 |
|
$0.04 |
|
$0.04 |
|